Location History:
- Bergenfield, NJ (US) (2001 - 2007)
- Belmont, MA (US) (2006 - 2008)
- Glen Rock, NJ (US) (2009)
Company Filing History:
Years Active: 2001-2009
Title: Innovations of Kenneth A. Jones
Introduction
Kenneth A. Jones is a notable inventor based in Bergenfield, NJ (US), recognized for his significant contributions to the field of biotechnology. He holds a total of 13 patents, showcasing his innovative spirit and dedication to advancing scientific knowledge.
Latest Patents
Among his latest patents are methods for preparing compositions using a SNORF33 receptor. This invention encompasses isolated nucleic acids encoding mammalian SNORF33 receptors, purified mammalian SNORF33 receptors, and vectors comprising nucleic acid encoding these receptors. Additionally, it includes cells that contain such vectors, antibodies directed to mammalian SNORF33 receptors, and nucleic acid probes useful for detecting nucleic acids encoding these receptors. The patent also covers antisense oligonucleotides complementary to unique sequences of nucleic acids encoding mammalian SNORF33 receptors, as well as transgenic, nonhuman animals that express DNA encoding normal or mutant mammalian SNORF33 receptors. Furthermore, it outlines methods for isolating mammalian SNORF33 receptors, treating abnormalities linked to their activity, and determining the binding of compounds to these receptors. The invention also identifies agonists and antagonists of SNORF33 receptors.
Another significant patent involves processes for determining compounds that interact with the SNORF33 receptor. This patent shares many similarities with the previous one, providing a comprehensive approach to understanding and utilizing the SNORF33 receptor in various applications.
Career Highlights
Kenneth has worked with prominent companies in the pharmaceutical and biotechnology sectors, including H. Lundbeck A/S and Synaptic Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Throughout his career, Kenneth has collaborated with notable professionals, including Beth E. Borowsky and Christophe P. G. Gerald. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Kenneth A. Jones is a distinguished inventor whose work on SNORF33 receptors has the potential to advance therapeutic approaches in biotechnology. His numerous patents reflect his commitment to innovation and the betterment of scientific understanding.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.